Evidence brief · printable

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

Print or save as PDF Fits on one A4 or Letter page.

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/myalgic-encephalomyelitis-chronic-fatigue-syndrome.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • A 3-day course 1 trial
  • Ampligen 1 trial
  • ASARM (see NCT02082730) 1 trial
  • Bupivacaine Injection 1 trial
  • Control group 1 trial
  • Cyclophosphamide 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Cognitive behavioural and related therapies 4 trials · 4 completed · 1 with results
  • Breathing and respiratory muscle training 2 trials · 2 completed · 1 with results
  • Vagus and cranial nerve stimulation 5 trials · 1 completed · 1 with results
  • Acupuncture and related techniques 6 trials · 3 completed · 0 with results
  • Multidisciplinary and other rehabilitation 5 trials · 2 completed · 0 with results
  • Light and laser therapy (photobiomodulation) 4 trials · 1 completed · 0 with results

Biomarkers reported

Direction in patients compared with the stated comparison group, as reported in the cited study.

  • Interleukin-1 (IL-1α/β) higher · Corbitt et al. 2019
  • Transforming Growth Factor-β (TGF-β) higher · Corbitt et al. 2019
  • Leptin higher · Strawbridge et al. 2019
  • Acylcarnitines (composite) lower · Jinushi et al. 2023 (meta-analysis, 7 studies)
  • C16 Acylcarnitine (palmitoylcarnitine) lower · Jinushi et al. 2023 (meta-analysis of pooled serum acylcarnitine; C16 not reported separately)
  • C18 Acylcarnitine (stearoylcarnitine) lower · Jinushi et al. 2023 (meta-analysis of pooled serum acylcarnitine; C18 not reported separately)

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue NCT06739720
  • Controlled Trial of Hydrogen Water as a Treatment for Myalgic… NCT07753122
  • Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in… NCT07009691
  • The Long COVID-19 Wearable Device Study NCT05741112
  • RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis NCT06933173
  • Internet-based Treatment for Patients Suffering From Severe Functional Somatic… NCT05525598

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 12 trials of oxygen, light, temperature and manual therapies found, none measured physical function and exercise capacity 11 trials of other approaches did
  • Among 12 trials of supplements and nutraceuticals found, none measured physical function and exercise capacity 11 trials of other approaches did
  • Among 8 trials of mind-body and psychological approaches found, none measured pain 8 trials of other approaches did
  • Oxygen, light, temperature and manual therapies: fatigue and energy 7 trials, no results posted yet
  • Supplements and nutraceuticals: fatigue and energy 5 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (63 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page · biomarker atlas. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.